spartalizumab
Showing 1 - 7 of 7
Oesophageal Adenocarcinoma, Gastric Adenocarcinoma Trial in France (Capmatinib, Spartalizumab)
Not yet recruiting
- Oesophageal Adenocarcinoma
- Gastric Adenocarcinoma
- Capmatinib
- Spartalizumab
- (no location specified)
Nov 15, 2021
NSCLC Trial in Worldwide (Capmatinib, Spartalizumab, Docetaxel)
Completed
- Carcinoma, Non-Small-Cell Lung
- Capmatinib
- +2 more
-
Fayetteville, Arkansas
- +7 more
Jan 21, 2022
Non-small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, Esophageal SCC Trial in Worldwide (TNO155, Spartalizumab,
Recruiting
- Non-small Cell Lung Carcinoma
- +4 more
- TNO155
- +2 more
-
Boston, Massachusetts
- +8 more
Mar 18, 2022
MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)
Recruiting
- MSI-H Colorectal Cancer
- +30 more
- Spartalizumab
-
Badalona, Barcelona, Spain
- +9 more
Aug 13, 2021
MDS, Leukemia, Myelomonocytic, Chronic Trial (decitabine, Spartalizumab, Sabatolimab)
Not yet recruiting
- Myelodysplastic Syndromes
- Leukemia, Myelomonocytic, Chronic
- decitabine
- +5 more
- (no location specified)
Aug 5, 2022
Nasopharyngeal Carcinoma Trial in Worldwide (Spartalizumab, Investigator choice of chemo)
Completed
- Nasopharyngeal Carcinoma
- Spartalizumab
- Investigator choice of chemotherapy
-
Marietta, Georgia
- +17 more
Jan 17, 2022